dostarlimab endometrial cancer

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
dostarlimab endometrial cancer	1.29	1	692	41	30
dostarlimab	0.39	1	9086	75	11
endometrial	0.24	0.2	3144	44	11
cancer	0.9	0.7	729	5	6

Keyword	CPC	PCC	Volume	Score
dostarlimab endometrial cancer	0.33	0.4	5195	55
dostarlimab endometrial cancer fda	0.8	0.8	6998	45
dostarlimab endometrial cancer fda approval	0.25	0.9	7331	24
dostarlimab endometrial cancer nejm	1.73	0.5	2462	8
dostarlimab endometrial cancer approval	1.02	0.5	6495	41
dostarlimab endometrial cancer nice	0.31	0.7	8943	80
dostarlimab endometrial cancer garnet	0.21	0.8	3400	84
dostarlimab and endometrial cancer	0.07	1	9335	45
dostarlimab fda approval colon cancer	1.56	1	1429	60
nice dostarlimab endometrial cancer	0.06	0.3	2694	63
dostarlimab for breast cancer	0.96	0.3	5082	38
dostarlimab fda approval news	0.11	0.8	4447	95
dostarlimab fda approval status	0.38	0.4	1066	81
dostarlimab breast cancer treatment	0.74	0.9	4645	16
is dostarlimab fda approved	1.38	0.9	5509	17
dostarlimab fda approval press release	0.96	0.2	3163	21
pembrolizumab fda approval endometrial cancer	0.18	0.9	358	97
dostarlimab fda approval history	1.76	0.3	8968	56
dostarlimab clinical trials colon cancer	0.96	0.7	7356	30
dostarlimab fda approval process	0.39	0.8	9139	59
dostarlimab fda approval timeline	0.37	1	409	91
dostarlimab fda approval letter	0.96	0.7	2748	32
dostarlimab fda approval criteria	1.28	0.1	4643	3